Hichain Biosciences Advances Nucleic Acid Therapeutics Leveraging Innovative Lipid Nanoparticle Delivery Platform

Currently, several forms of nucleic acid drugs have been developed in clinical practice, including mRNA vaccines, small interfering RNA (siRNA), and antisense oligonucleotides (ASO). According to a report released by Mordor Intelligence, the global nucleic acid therapeutics market size has reached nearly 5 billion US dollars and is expected to reach 9.54 billion US dollars by 2028. At present, capital continues to pour into this field.